Page 344 - Hematology_ Basic Principles and Practice ( PDFDrive )

284.e2 Part III Immunologic Basis of Hematology

47. Lee SC, Brummet ME, Shahabuddin S, et al: Cutaneous injection 72. Takeda J, Miyata T, Kawagoe K, et al: Deficiency of the GPI anchor
of human subjects with macrophage inflammatory protein-1 alpha caused by a somatic mutation of the PIG-A gene in paroxysmal noc-
induces significant recruitment of neutrophils and monocytes. J turnal hemoglobinuria. Cell 73:703, 1993.
Immunol 164:3392, 2000. 73. Carroll MC: The lupus paradox. Nat Genet 19:3, 1998.
48. DiScipio RG, Daffern PJ, Jagels MA, et al: A comparison of C3a and 74. Paul E, Carroll MC: SAP-less chromatin triggers systemic lupus erythe-
C5a-mediated stable adhesion of rolling eosinophils in postcapillary matosus. Nat Med 5:607, 1999.
venules and transendothelial migration in vitro and in vivo. J Immunol 74a. Chatterjee P, Agyemang AF, Alimzhanov MB, et al: Complement
162:1127, 1999. C4 maintains peripheral B-cell tolerance in a myeloid cell dependent
49. Foreman KE, Glovsky MM, Warner RL, et al: Comparative effect of manner. Eur J Immunol 43:2441–2450, 2013.
C3a and C5a on adhesion molecule expression on neutrophils and 74b. Das A, Heesters BA, Bialas A, et al: Follicular dendritic cell activa-
endothelial cells. Inflammation 20:1, 1996. tion by TLR ligands promotes autoreactive B cell responses. Immunity
50. Kohl J: Anaphylatoxins and infectious and non-infectious inflammatory 46:106, 2017.
diseases. Mol Immunol 38:175, 2001. 75. Nussenzweig V, Bianco C, Dukor P, et al: Receptors for C3 of B
51. Liszewski MK, Farries TC, Lublin DM, et al: Control of the comple- lymphocytes: Possible role in the immune response. In Amos B, editor:
ment system. Adv Immunol 61:201, 1996. Progress in immunology, New York, 1971, Academic Press.
52. Davis AE, 3rd: C1 inhibitor and hereditary angioneurotic edema. Annu 76. Pepys MB: Role of complement in induction of antibody production
Rev Immunol 6:595, 1988. in vivo. Effect of cobra factor and other C3-reactive agents on thymus-
53. Ollert MW, Kadlec JV, David K, et al: Antibody-mediated complement dependent and thymus-independent antibody responses. J Exp Med
activation on nucleated cells. A quantitative analysis of the individual 140:126, 1974.
reaction steps. J Immunol 153:2213, 1994. 77. Bitter-Suermann D, Burger R: C3 deficiencies. Curr Top Microbiol
54. Holers VM, Kinoshita T, Molina H: The evolution of mouse and Immunol 153:223, 1990.
human complement C3-binding proteins: Divergence of form but 78. Böttger EC, Metzger S, Bitter-Suermann D, et al: Impaired humoral
conservation of function. Immunol Today 13:231, 1992. immune response in complement C3-deficient guinea pigs: Absence of
55. Xu C, Mao D, Holers VM, et al: A critical role for murine complement secondary antibody response. Eur J Immunol 16:1231, 1986.
regulator crry in fetomaternal tolerance. Science 287:498, 2000. 79. O’Neil KM, Ochs HD, Heller SR, et al: Role of C3 in humoral immu-
56. Petry F: Molecular basis of hereditary C1q deficiency. Immunobiology nity. Defective antibody production in C3-deficient dogs. J Immunol
199:286, 1998. 140:1939, 1988.
57. Walport MJ, Davies KA, Botto M: C1q and systemic lupus erythema- 80. Finco O, Li S, Cuccia M, et al: Structural differences between the two
tosus. Immunobiology 199:265, 1998. human complement C4 isotypes affect the humoral immune response.
58. Carroll MC, Campbell RD, Bentley DR, et al: A molecular map of J Exp Med 175:537, 1992.
the human major histocompatibility complex class III region linking 81. Jackson CG, Ochs HD, Wedgwood RJ: Immune response of a patient
complement genes C4, C2 and factor B. Nature 307:237, 1984. with deficiency of the fourth component of complement and systemic
59. Carroll MC, Fathallah DM, Bergamaschini L, et al: Substitution of a lupus erythematosus. N Engl J Med 300:1124, 1979.
single amino acid (aspartic acid for histidine) converts the functional 82. Cutler AJ, Botto M, van Essen D, et al: T cell-dependent immune
activity of human complement C4B to C4A. Proc Natl Acad Sci U S A response in C1q-deficient mice: Defective interferon gamma produc-
87:6868, 1990. tion by antigen-specific T cells. J Exp Med 187:1789, 1998.
60. Bala Subramanian V, Lin M, Atkinson JP: The complement system and 83. Da Costa XJ, Brockman MA, Alicot E, et al: Humoral response to
autoimmunity. In Chiorazzi N, Lahita R, Reeves W, editors: Textbook herpes simplex virus is complement-dependent. Proc Natl Acad Sci U S
of autoimmune diseases, Philadelphia, PA, 2000, Lippincott-Raven. A 96:12708, 1999.
61. Carroll MC: The role of complement in B cell activation and tolerance. 84. Fischer MB, Ma M, Goerg S, et al: Regulation of the B cell response
Adv Immunol 74:61, 2000. to T-dependent antigens by classical pathway complement. J Immunol
62. Cicardi M, Bergamaschini L, Cugno M, et al: Pathogenetic and 157:549, 1996.
clinical aspects of C1 inhibitor deficiency. Immunobiology 199:366, 85. Ochsenbein AF, Pinschewer DD, Odermatt B, et al: Protective T cell-
1998. independent antiviral antibody responses are dependent on comple-
63. Densen P: Complement deficiencies and infection. In Volanakis JE, ment. J Exp Med 190:1165, 1999.
Frank MM, editors: The human complement system in health and disease, 86. Kelsoe G: B cell diversification and differentiation in the periphery. J
New York, 1998, Marcel Dekker, p 409. Exp Med 180:5, 1994.
64. Kavanaugh D, Richards A, Atkinson J: Complement regulatory genes 87. Fischer MB, Goerg S, Shen L, et al: Dependence of germinal center B
and hemolytic uremic syndromes. Annu Rev Med 59:293, 2008. cells on expression of CD21/CD35 for survival. Science 280:582, 1998.
65. Fremeaux-Bacchi V, Miller EC, Liszewski K, et al: Mutations in 88. Gadjeva M, Verschoor A, Brockman MA, et al: Macrophage-derived
complement C3 predispose to development of atypical hemolytic complement component C4 can restore humoral immunity in
uremic syndrome. Blood 112:4948, 2008. C4-deficient mice. J Immunol 169:5489, 2002.
66. Kajander T, Lehtinen MJ, Hyvärinen S, et al: Dual interaction of factor 89. Boes M, Esau C, Fischer MB, et al: Enhanced B-1 cell development,
H with C3d and glycosaminoglycans in host-nonhost discrimination but impaired IgG antibody responses in mice deficient in secreted IgM.
by complement. Proc Natl Acad Sci U S A 108:2897, 2011. J Immunol 160:4776, 1998.
67. Edwards AO, Ritter R, 3rd, Abel KJ, et al: Complement factor H 90. Rossbacher J, Shlomchik MJ: The B cell receptor itself can activate
polymorphism and age-related macular degeneration. Science 308:421, complement to provide the complement receptor 1/2 ligand required
2005. to enhance B cell immune responses in vivo. J Exp Med 198:591,
68. Klein RJ, Zeiss C, Chew EY, et al: Complement factor H poly- 2003.
morphism in age-related macular degeneration. Science 308:385, 91. Manderson AP, Quah B, Botto M, et al: A novel mechanism for
2005. complement activation at the surface of B cells following antigen
69. Clark SJ, Bishop PN, Day AJ: Complement factor H and age-related binding. J Immunol 177:5155, 2006.
macular degeneration: The role of glycosaminoglycan recognition in 92. Dempsey PW, Allison ME, Akkaraju S, et al: C3d of complement as
disease pathology. Biochem Soc Trans 38:1342, 2010. a molecular adjuvant: Bridging innate and acquired immunity. Science
70. Atkinson JP, Bessler M: Paroxysmal nocturnal hemoglobinuria. In Perl- 271:348, 1996.
mutter J, Stamatoyannopoulos JA, Majerus PW, editors: The molecular 93. Ross TM, Xu Y, Bright RA, et al: C3d enhancement of antibodies to
basis of blood disease, Philadelphia, 2000, WB Saunders, p 564. hemagglutinin accelerates protection against influenza virus challenge.
71. Motoyama N, Okada N, Yamashina M, et al: Paroxysmal nocturnal Nat Immunol 1:127, 2000.
hemoglobinuria due to hereditary nucleotide deletion in the HRF20 94. Kinoshita T, Takeda J, Hong K, et al: Monoclonal antibodies to mouse
(CD59) gene. Eur J Immunol 22:2669, 1992. complement receptor type 1 (CR1). Their use in a distribution study